AI in Drug Discovery Conference 2020
Event Mar 16 - Mar 17, 2019
SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London on 16th-17th March 2020.
AI-empowered machine learning technologies hold the potential of reducing drug discovery associated costs by US$ 70 billion in the upcoming 10 years. With an estimated +39% CAGR, AI in drug discovery is leading the way into a shorter, cheaper and more successful R&D era where compound generation is automated, drug synthesis is predictable and undruggable diseases are finally being targeted.
The presence of AI in drug discovery is tangible with the majority of drug discovery scientist already working with AI-enabled platforms using machine learning and deep learning, neural networks and natural language processing. However, there is a long journey ahead of optimizing AI-human connections and understanding the full potential of AI-enabled tools and platforms.
To register please visit: www.AI-indrugdiscovery.com/tecnetwl
PLUS, one interactive half-day post-conference workshop
Practical application of predictive properties in drug design, Workshop Leader: Robert Young, Blue Burgundy Ltd.
BOOK BY 29TH NOVEMBER AND SAVE £400
BOOK BY 13TH DECEMBER AND SAVE £200
BOOK BY 31ST JANUARY AND SAVE £100
SOCIAL MEDIA HANDLES
Twitter: @SMiPharm #SMiDrugdiscovery
LinkedIn: follow our company page – search ‘SMi Pharma’